Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Engineering human chromosomes for gene therapy studies.

K H Choo

    Trends in Molecular Medicine
    |May 30, 2001
    PubMed
    Summary
    This summary is machine-generated.

    Engineered human chromosomes offer a novel gene therapy vector. These vectors can carry large therapeutic genes without disrupting the genome or causing immune responses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Susceptibility of metallothionein-null mice to paraquat.

    Environmental toxicology and pharmacology·2011
    Same author

    Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio.

    Human molecular genetics·2010
    Same author

    Removal of manganese from water using combined chelation/membrane separation systems.

    Water science and technology : a journal of the International Association on Water Pollution Research·2005
    Same author

    A pilot-scale photocatalyst-membrane hybrid reactor: performance and characterization.

    Water science and technology : a journal of the International Association on Water Pollution Research·2005
    Same author

    Domain organization at the centromere and neocentromere.

    Developmental cell·2001
    Same author

    Mosaic inv dup(8p) marker chromosome with stable neocentromere suggests neocentromerization is a post-zygotic event.

    American journal of medical genetics·2001

    Area of Science:

    • Genetics
    • Molecular Biology
    • Gene Therapy

    Background:

    • Development of engineered human chromosomes as vectors for gene delivery.
    • Exploration of their potential in gene therapy applications.

    Discussion:

    • Advantages include non-disruptive genomic integration, non-immunogenicity, and capacity for large therapeutic genes with regulatory sequences.
    • Addressing the challenges and future prospects of this technology.

    Key Insights:

    • Engineered human chromosomes represent a promising advancement in gene therapy vector technology.
    • These vectors overcome limitations of traditional gene delivery systems.

    Outlook:

    • Potential for treating genetic disorders by delivering large therapeutic genes effectively.

    Related Experiment Videos

  • Future research directions and clinical applications of engineered chromosome vectors.